Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ExeQOL: Exenatide vs Insulin on Quality of Life in CABG Patients
NCT02432976Phase 3Completed
- Sponsor
- CHU de Besançon
- Start
- May 2015
- Primary completion
- Jan 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of exenatide in hyperglycemia, sponsored by CHU de Besançon. Started May 2015; status: completed.
02
Drugs
exenatide
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT02432976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432976.